📰 Trial Network News
Page 7 - Trial Network News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Trial Network. Real-time updates on events, politics, business and more.
March 25, 2023
Bob Fulton Hill Ward Henderson currently serves on the firm’s Management Committee, and on the Diversity & Inclusion and Wellness Committees. He defends companies in products liability.
February 23, 2023
The outcome of the treatment has been promising, and doctors declared the patient cured. Stem cell-related treatment has been used for various reasons, but perhaps the most progressive application is its effectiveness in curing a few cases of HIV.
September 23, 2022
Individuals with memory problems encouraged to learn more about study
September 15, 2022
The immunotherapy firm will use Caris' "Right-In-Time" clinical trial network to recruit eligible patients for a trial of its cell-based treatment, Bria-IMT.
July 19, 2022
/PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help protect people from infectious...
June 20, 2022
GuruFocus Article or News written by PRNewswire and the topic is about:
June 12, 2022
Reaffirming its leadership in introducing state-of-the-art Mobile technology to Sri Lanka, SLT-MOBITEL, the National ICT Solutions Provider, has expanded its 5G pre-commercial trial network across main cities in the country; setting a pathway for customers to experience the transformational power of 5G technology in both Mobile Broadband and Fixed Wireless Access domains. Customers with a...
June 9, 2022
Convenient, Fast, Enterprise Grade Secure Public Wi-Fi Showcased in Chicago Chicago, USA, June 9 2022: The Wireless Broadband Alliance (WBA) today announced that it will provide Wireless Global Congress attendees and visitors with free, seamless access to OpenRoaming™ Wi-Fi hotspots throughout the conference, held June 6-9 at the Hilton Palmer House Hotel in Chicago...
May 27, 2022
/PRNewswire/ -- INOVIO (NASDAQ: INO) announced results from the companys novel Phase 1/2 trial of INO-5401 and INO-9012 in combination with PD-1 inhibitor...
May 11, 2022
Announces prioritization of heterologous booster strategy for COVID-19 vaccine candidate INO-4800 and discontinuation of Phase 3 INNOVATE trial to optimize...